---
title: "China Stocks Rebound on Dip Buying"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251398997.md"
description: "China's stock market saw a rebound on Monday, with the Shanghai Composite rising 0.66% to 3,583 and the Shenzhen Component increasing by 0.46% to 11,042. This uptick was driven by investors buying the dip following last week's decline. However, concerns linger as the recent Politburo meeting did not introduce significant stimulus measures to combat slowing growth. Traders are also monitoring the US-China tariff situation, with the current truce set to expire on August 12. Notable gainers included Contemporary Amperex (1.3%), Dosilicon Co (20%), and Hybio Pharmaceuticals (20%)."
datetime: "2025-08-04T07:30:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251398997.md)
  - [en](https://longbridge.com/en/news/251398997.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251398997.md)
generator: "portal-rs"
---

# China Stocks Rebound on Dip Buying

The Shanghai Composite rose 0.66% to 3,583 and the Shenzhen Component gained 0.46% to 11,042 on Monday, as investors stepped in to buy the dip after last week’s pullback.

Bargain hunting helped lift sentiment, though signs of fading momentum remain as last week’s Politburo meeting offered no major new stimulus to address slowing growth and deflationary pressures, disappointing hopes for stronger policy support.

Traders also kept a close watch on trade developments, with the current US-China tariff truce still awaiting extension ahead of its August 12 expiration.

Upcoming trade and inflation data may provide further insight into the early effects of the fragile agreement.

Among standout gainers were Contemporary Amperex (1.3%), Dosilicon Co (20%), and Hybio Pharmaceuticals (20%).

### Related Stocks

- [300199.CN](https://longbridge.com/en/quote/300199.CN.md)
- [688110.CN](https://longbridge.com/en/quote/688110.CN.md)

## Related News & Research

- [174K Reasons To Be Bullish On Taiwan Semiconductor Stock](https://longbridge.com/en/news/296634361.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [HENGRUI PHARMA  1H26 Net Profit Rises 0.3% YoY to RMB4.465 Billion; Shares Now Down Over 7%](https://longbridge.com/en/news/296422700.md)
- [CANSINOBIO  Tetanus Vaccine New Drug Application Approved](https://longbridge.com/en/news/296498620.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**